{"id":791,"date":"2020-09-24T10:38:12","date_gmt":"2020-09-24T16:38:12","guid":{"rendered":"https:\/\/www.canadiancancercare.com\/?page_id=791"},"modified":"2023-04-15T10:51:22","modified_gmt":"2023-04-15T16:51:22","slug":"prostate-cancer-surveillance-and-survivorship-clinic","status":"publish","type":"page","link":"https:\/\/www.canadiancancercare.com\/index.php\/prostate-cancer-surveillance-and-survivorship-clinic\/","title":{"rendered":"Prostate Cancer Surveillance and Survivorship Clinic"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Prostate Cancer Surveillance and Survivorship Clinic<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

After treatment for prostate cancer, such as surgery or radiation therapy, regular follow-up and surveillance are typically recommended to monitor for any signs of recurrence or treatment-related side effects. The specific surveillance plan may vary depending on the type and stage of the prostate cancer, the treatment received, and individual patient factors.\u00a0 However, here are some general recommendations for surveillance after treatment for prostate cancer:<\/p>

  1. Regular PSA monitoring:<\/strong> Regular monitoring of prostate-specific antigen (PSA) levels is typically a key component of post-treatment surveillance for prostate cancer. PSA levels can be used to track changes over time and may indicate if the cancer is returning or progressing. The frequency of PSA testing may vary depending on the individual case, but it is typically done every 3-6 months initially, and then less frequently as time goes on.<\/p><\/li>

  2. Physical examinations:<\/strong> Regular physical examinations, including digital rectal examination (DRE), may be performed as part of post-treatment surveillance to assess the prostate gland and surrounding areas for any signs of recurrence or other abnormalities.<\/p><\/li>

  3. Imaging tests<\/strong>: Imaging tests such as magnetic resonance imaging (MRI), computed tomography (CT) scans, or bone scans may be recommended periodically to assess the prostate area and surrounding tissues for any signs of recurrence or metastasis.<\/p><\/li>

  4. Hormone therapy<\/strong>: If hormone therapy was part of the treatment plan for prostate cancer, regular monitoring of hormonal levels and potential side effects may be necessary.<\/p><\/li>

  5. Monitoring for treatment-related side effects:<\/strong> Post-treatment surveillance may also involve monitoring for any treatment-related side effects, such as urinary or bowel symptoms, sexual dysfunction, or other potential complications from the treatment received.<\/p><\/li>

  6. Lifestyle changes:<\/strong> Adopting a healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking and excessive alcohol consumption, may also be recommended to support overall health and well-being during post-treatment surveillance.<\/p><\/li>

  7. Shared decision-making:<\/strong> Post-treatment surveillance should involve shared decision-making between the patient and their healthcare provider, taking into consideration the patient’s overall health, treatment history, and individual risk factors.<\/p><\/li><\/ol>

    It’s important to note that the recommendations for post-treatment surveillance may vary depending on the specific circumstances and should be tailored to the individual patient’s needs. Regular follow-up and communication are essential to ensure appropriate surveillance and early detection of any potential recurrence or complications.<\/p>

    Request an appointment<\/a>, no referral required.\u00a0 All services are covered under the Alberta Health Care Insurance Plan.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t\t
    \"CDN<\/figure><\/div>
    \"CDN<\/figure><\/div>
    \"CDN<\/figure><\/div>
    \"CDN<\/figure><\/div>
    \"\"<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t
    \n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t
    <\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    Prostate Cancer Surveillance and Survivorship Clinic After treatment for prostate cancer, such as surgery or radiation therapy, regular follow-up and surveillance are typically recommended to monitor for any signs of recurrence or treatment-related side effects. The specific surveillance plan may vary depending on the type and stage of the prostate cancer, the treatment received, and […]<\/p>\n","protected":false},"author":1,"featured_media":180,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-parts\/template-homepage.php","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-791","page","type-page","status-publish","has-post-thumbnail","hentry"],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P9NM6Q-cL","_links":{"self":[{"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/pages\/791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/comments?post=791"}],"version-history":[{"count":6,"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/pages\/791\/revisions"}],"predecessor-version":[{"id":1105,"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/pages\/791\/revisions\/1105"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/media\/180"}],"wp:attachment":[{"href":"https:\/\/www.canadiancancercare.com\/index.php\/wp-json\/wp\/v2\/media?parent=791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}